Vaccines for Peace: An International Program of Development and Use of Vaccines Against Dual-Threat Agents

1992 ◽  
Vol 11 (2) ◽  
pp. 231-243 ◽  
Author(s):  
Erhard Geissler

This article recommends establishment of an international Vaccines for Peace (VFP) program to undertake research on and production of vaccines against pathogens (and possibly toxins) that pose natural health threats and that are also putative biological (and toxin) weapons. Vaccines for Peace is designed to contribute to health care in developing countries, enhance international cooperation in biotechnology, and reduce the danger of weapons proliferation. Vaccine development would be carried out openly and would involve scientists from developing countries that are States Parties to the Biological Weapons Convention, as well as personnel and facilities from the former Soviet Union. The program would thus help convert biological defense personnel and facilities to peaceful purposes. The program would be administered by the World Health Organization.

2020 ◽  
Vol 1 (2) ◽  
pp. 01-06
Author(s):  
Robert Skopec

Dr. Francis Boyle, who drafted the Biological Weapons Act has given a detailed statement admitting that the 2019 Wuhan Coronavirus is an offensive Biological Warfare Weapon and that the World Health Organization (WHO) already knows about it. Francis Boyle is a professor of international law at the University of Illinois College of Law. He drafted the U.S. domestic implementing legislation for the Biological Weapons Convention, known as the Biological Weapons Anti-Terrorism Act of 1989, that was approved unanimously by both Houses of the U.S. Congress and signed into law by President George H.W. Bush.


1993 ◽  
Vol 12 (1) ◽  
pp. 87-89
Author(s):  
Graham S. Pearson

The Article in the August, 1992 issue of Politics and the Life Sciences by Erhard Geissler proposing the establishment of an international Vaccines for Peace (VFP) program to undertake research on and production of vaccines against pathogens (and possible toxins) that pose natural health threats is warmly welcomed. VFP is designed to contribute to health care in developing countries and to enhance international cooperation in biotechnology; it would be administered by the World Health Organization (WHO). Such a program would bring real and tangible benefits to developing countries and encourage participation by such countries in the Biological and Toxin Weapons Convention signed in 1972.


2006 ◽  
Vol 11 (12) ◽  
Author(s):  
D Falzon ◽  
J C Desenclos

In 2004, 414 163 tuberculosis cases were notified by 51 of the 52 countries of the World Health Organization European Region, representing 8% of notifications to WHO worldwide in the same year. Seventy per cent of all TB cases in the region were in the 12 countries of the Former Soviet Union


2008 ◽  
Vol 13 (12) ◽  
pp. 3-4 ◽  
Author(s):  
D Falzon ◽  
Y Kudjawu ◽  
J C Desenclos ◽  
K Fernandez de la Hoz ◽  
A Dadu ◽  
...  

Overview of the epidemiological situation in 2006. The latest available information from countries in the World Health Organization (WHO) European Region carries important signals about the tuberculosis (TB) situation in this part of the world [1]. The total number of TB cases reported in the Region was slightly lower in 2006 than in 2005 (422,830 versus 426,457), reflecting a decrease in three-fourths of the reporting countries. Most TB cases in 2006 (73%) were reported by 12 former Soviet Union republics in the East, 21% by the European Union and West (EU and West) and 6% by the remaining countries in the Balkans (Table 1; for the composition of geographical areas see Box). National TB notification rates ranged from 4 to 282 per 100,000 population. The total TB notification rate for the whole Region has increased very slightly between 2002 and 2006, from 46 to 48 cases per 100,000, although rates of previously untreated TB cases appear to be on the decrease in both the East and West (Figure 1). We describe the main epidemiological features of TB cases notified in each of the abovementioned areas using surveillance data reported by the countries themselves.


1997 ◽  
Vol 16 (1) ◽  
pp. 105-126 ◽  
Author(s):  
Malcolm R. Dando ◽  
Graham S. Pearson

The Fourth Review Conference of the Biological and Toxin Weapons Convention was held November 25 to December 6, 1996. It successfully re-emphasized the norm against biological warfare, usefully broadening this to include molecular biology and applications resulting from genome studies. It also emphasized that use in any way and under any circumstances would be a violation of Article I. Disappointingly, compliance concerns regarding Iraq and the former Soviet Union were less strongly addressed. Article IV and the importance of national legislation as a potential counter to possible terrorist use was underlined. The importance of the existing confidence-building measures (CBMs) was confirmed and the work of the Ad Hoc Group was strongly endorsed, with a change to a negotiating format being explicitly stated, although without setting the target date of 1998 for completion. Article X was re-emphasized, with special note made of the advances made at the Rio Summit, Agenda 21, the Convention on Biological Diversity, and of the initiatives being taken by the World Health Organization to counter new, emerging, and re-emerging infectious diseases. This article addresses the issues, outcomes, and unfinished business of the Fourth Review Conference.


2002 ◽  
Vol 26 (5) ◽  
pp. 185-188 ◽  
Author(s):  
S. R. Collinson ◽  
T. H. Turner

Given the marginal nature of psychiatry in terms of Western health priorities, it is always worth reviewing how countries with clearly different political systems treat their mentally ill. The 40-year economic embargo imposed by the USA on Cuba, the effects of which have been compounded by the hardships suffered during the ‘Special Period’ from 1989 onwards when the collapse of the Soviet Union left the island's economy in ruins (Pilling, 2001), is one of the most stringent of its kind. It prohibits the sale of food, and sharply restricts the sale of medicines and medical equipment, which, given the USA's pre-eminence in the pharmaceutical industry, effectively bars Cuba from purchasing nearly half of the new world class drugs on the market (Rojas Ochoa, 1997). Between 1989 and 1993, Cuba's gross domestic product fell by 35% and exports declined by 75% (Pan American Health Organisation, 1999). This has reduced the availability of resources and has adversely affected some health determinants and certain aspects of the population's health status. Despite this, however, Cuba has developed a system prioritised to primary and preventive care, with an infant mortality rate half that of the city of Washington, DC (World Health Organization & Pan American Health Organization, 1997; Casas et al, 2001). Furthermore, biotechnology and family medicine are being developed by Cuba as a human resource for other developing countries. Cuban medical schools also train physicians specifically for many developing countries around the world (Waitzkin et al, 1997).


Author(s):  
Erlangga Yusuf

<p align="left">According to the World Health Organization (WHO), primary health care (PHC) can be defined as a whole-of-society approach to health and well-being, centered on the needs and preferences of individuals, families and communities. In the last five years, several major events occurred that emphasize the importance of and the need for PHC. First, the publication of the United Nations Sustainable Development Goals (SDGs) in 2015. One of the SDGs is to achieve universal health care (UHC). UHC means that all people can get access to health service without it resulting in financial hardship, and  the WHO believes that PHC is fundamental to achieving UHC.<sup><span> </span></sup>Second, a new international declaration on PHC has been released in Astana, Kazakhstan, in 2018.<span style="font-size: 8.33333px;"> </span>This is a new declaration and global commitment on PHC, four decennia after the first declaration on PHC in Alma-Ata, in the former Soviet Union</p>


2020 ◽  
Vol 7 (3) ◽  
pp. 1-7
Author(s):  
Robert Skopec ◽  

Dr. Francis Boyle, who drafted the Biological Weapons Act has given a detailed statement admitting that the 2019 Wuhan Coronavirus is an offensive Biological Warfare Weapon and that the World Health Organization (WHO) already knows about it. Francis Boyle is a professor of international law at the University of Illinois College of Law. He drafted the U.S. domestic implementing legislation for the Biological Weapons Convention, known as the Biological Weapons Anti-Terrorism Act of 1989, that was approved unanimously by both Houses of the U.S. Congress and signed into law by President George H.W. Bush.


2020 ◽  
Vol 27 ◽  
Author(s):  
Kush K. Maheshwari ◽  
Debasish Bandyopadhyay

Background: Neglected tropical diseases (NTDs) affect a huge population of the world and majority of the victims belong to the poor community of the developing countries. Until now, the World Health Organization (WHO) has identified 20 tropical diseases as NTDs that must be addressed with high priority. However, many heterocyclic scaffolds have demonstrated potent therapeutic activity against several NTDs. Objective: There are three major objectives: (1) To discuss the causes, symptoms, and current status of all the 20 NTDs; (2) To explore the available heterocyclic drugs, and their mechanism of actions (if known) that are being used to treat NTDs; (3) To develop general awareness on NTDs among the medicinal/health research community and beyond. Methods: The 20 NTDs have been discussed according to their alphabetic orders along with the possible heterocyclic remedies. Current status of treatment with an emphasis on the heterocyclic drugs (commercially available and investigational) has been outlined. In addition, brief discussion of the impacts of NTDs on socio-economic condition is included. Results: NTDs are often difficult to diagnose and the problem is worsened by the unhealthy hygiene, improper awareness, and inadequate healthcare in the developing countries where these diseases primarily affect poor people. The statistics include duration of suffering, numbers affected, and access to healthcare and medication. The mechanism of actions of various heterocyclic drugs, if reported, have been briefly summarized. Conclusion: Scientists and pharmaceutical corporations should allocate more resources to reveal the in-depth mechanism of actions of many heterocyclic drugs that are currently being used for the treatment of NTDs. Analysis of current heterocyclic compounds and development of new medications can help in the fight to reduce/remove the devastating effects of NTDs. An opinion-based concise review has been presented. Based on available literature, this is the first effect to present all the 20 NTDs and related heterocyclic compounds under the same umbrella.


Sign in / Sign up

Export Citation Format

Share Document